Serine/threonine kinase

From WikiMD's Wellness Encyclopedia

Serine/threonine kinase (STK) is a type of enzyme that phosphorylates the amino acids serine and threonine in proteins. This action is critical in the regulation of many cellular processes, including cell cycle, apoptosis (programmed cell death), signal transduction pathways, and cell differentiation. Serine/threonine kinases are part of a larger family of protein kinases, which are essential to cellular communication and the control of cellular responses to external and internal stimuli.

Function[edit | edit source]

Serine/threonine kinases transfer a phosphate group from adenosine triphosphate (ATP) to the hydroxyl group of serine or threonine residues in protein substrates. This phosphorylation event can activate or deactivate the substrate protein, thereby altering its function and the cellular process in which it is involved. The specific outcomes of serine/threonine kinase activity depend on the substrate targeted and the context within the cell. These enzymes play a pivotal role in the regulation of numerous pathways, including those involved in metabolism, cell growth, and immune response.

Classification[edit | edit source]

Serine/threonine kinases can be classified into several families based on their structural features and substrate specificities. Some of the major families include:

Role in Disease[edit | edit source]

Abnormalities in serine/threonine kinase function can lead to a variety of diseases. For example, mutations in specific kinases have been associated with cancer, diabetes, and neurodegenerative diseases. In cancer, certain serine/threonine kinases may become overactive, leading to uncontrolled cell growth and tumor development. Conversely, in neurodegenerative diseases like Alzheimer's disease, abnormal phosphorylation of proteins such as tau by serine/threonine kinases can contribute to disease progression.

Therapeutic Implications[edit | edit source]

Given their central role in many critical cellular processes, serine/threonine kinases have become important targets for drug development. Inhibitors of specific kinases are being developed and used in the treatment of diseases such as cancer and inflammatory disorders. These inhibitors can selectively block the activity of aberrant kinases, thereby correcting the underlying cellular dysfunctions.

See Also[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD